Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction

螺内酯 医学 危险系数 心房颤动 心力衰竭 内科学 心脏病学 射血分数 随机化 置信区间 随机对照试验
作者
Maja Čikeš,Brian Claggett,Amil M. Shah,Akshay S. Desai,Eldrin F. Lewis,Sanjiv J. Shah,Inder S. Anand,Eileen O’Meara,Jean L. Rouleau,Nancy K. Sweitzer,James C. Fang,Sanjeev Saksena,Bertram Pitt,Marc A. Pfeffer,Scott D. Solomon
出处
期刊:Jacc-Heart Failure [Elsevier BV]
卷期号:6 (8): 689-697 被引量:79
标识
DOI:10.1016/j.jchf.2018.05.005
摘要

This study assessed the relationship between atrial fibrillation (AF) and outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial, to evaluate whether AF modified the treatment response to spironolactone and whether spironolactone influenced post-randomization AF.AF is common in heart failure with preserved ejection fraction (HFpEF) and likely contributes to increased risk of adverse outcomes.A total 1,765 patients enrolled in TOPCAT trial in North and South America were divided into 3 groups: no known AF, history of AF without AF at enrollment, and AF found on the electrocardiogram (ECG) at enrollment. We assessed outcomes and treatment response to spironolactone in all groups, and the association between post-randomization AF and outcomes in patients free of AF at baseline. The primary outcome of the TOPCAT trial was a composite of cardiovascular mortality, aborted cardiac arrest, or heart failure hospitalization.A total of 760 patients (43%) had a history of AF (18%) or AF on ECG at enrollment (25%). The highest adjusted risk was associated with AF at enrollment (primary outcome, hazard ratio: 1.34; 95% confidence interval: 1.09 to 1.65; p = 0.006; and an increased early risk of secondary outcomes). Neither history of AF nor AF at enrollment modified the beneficial treatment effect of spironolactone. Post-randomization AF, which occurred in 6.3% of patients, was not influenced by spironolactone treatment, but was associated with an increased early risk of the primary outcome (hazard ratio: 2.32; 95% confidence interval: 1.59 to 3.40; p < 0.0001) and secondary outcomes.AF at enrollment was associated with increased cardiovascular risk in HFpEF patients in the TOPCAT study. Post-randomization AF, which was associated with an increased risk of morbidity and mortality, was not influenced by spironolactone. (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist [TOPCAT]; NCT00094302).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小明完成签到,获得积分10
1秒前
拙青发布了新的文献求助10
1秒前
小茶完成签到 ,获得积分10
2秒前
007完成签到,获得积分10
4秒前
LSS完成签到,获得积分10
6秒前
快乐小夏发布了新的文献求助30
7秒前
不许不行完成签到,获得积分10
8秒前
8秒前
刻苦青烟完成签到 ,获得积分10
10秒前
摸鱼大王完成签到 ,获得积分10
12秒前
邪恶青年发布了新的文献求助10
13秒前
XIXIHAHA完成签到 ,获得积分10
15秒前
李云穆完成签到,获得积分10
16秒前
华仔的应助被含糊的万恶采纳,获得10
16秒前
科学追求者完成签到,获得积分10
17秒前
DDF完成签到 ,获得积分10
20秒前
liuguohua126完成签到,获得积分10
20秒前
zher完成签到,获得积分10
20秒前
www完成签到 ,获得积分10
22秒前
juan完成签到 ,获得积分10
24秒前
25秒前
北暖完成签到 ,获得积分10
25秒前
AA18236931952完成签到,获得积分10
25秒前
邪恶青年完成签到,获得积分10
29秒前
初晴发布了新的文献求助10
30秒前
尔安完成签到,获得积分10
32秒前
开始游戏55完成签到,获得积分10
32秒前
杰_骜不驯完成签到,获得积分10
33秒前
杏仁和巧克力完成签到 ,获得积分10
35秒前
Akim的应助被初晴采纳,获得10
36秒前
正直的擎宇完成签到,获得积分10
37秒前
上官若男的应助被魔幻灵煌采纳,获得10
37秒前
Beton_X完成签到,获得积分10
38秒前
38秒前
sfliufighting完成签到,获得积分10
39秒前
40秒前
学术小白two完成签到,获得积分10
42秒前
广阔天地完成签到 ,获得积分10
43秒前
清秀斓发布了新的文献求助30
44秒前
mm完成签到,获得积分0
44秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Composite Materials Handbook Volume 1 - Revision H 1500
Composite Materials Handbook Volume 3 - Revision H 1500
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7806998
求助须知:如何正确求助?哪些是违规求助? 9339781
关于积分的说明 20498516
捐赠科研通 7399183
什么是DOI,文献DOI怎么找? 3328267
关于科研通互助平台的介绍 2475124
邀请新用户注册赠送积分活动 2346566